About Guillain-Barré Syndrome

From the nation’s leading law firm representing victims of Campylobacter and other foodborne illness outbreaks.

Chapter 6

References

  1. Willison HJ, Jacobs BC, van Doorn PA. (2016). Guillain-Barré syndrome. Lancet. 388(10045):717-27.
  2. Toscano G, et al. (2020). Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 382(26):2574-6.
  3. Hadden RD, et al. (1998). Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol. 44(5):780-8.
  4. Nishimoto Y, Odaka M, Hirata K, Yuki N. (2004). Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol. 148(1-2):200-5.
  5. Hughes RAC, et al. (2003). Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 61(6):736-40.
  6. Patwa HS, Chaudhry V, Katzberg H, Rae-Grant AD, So YT. (2012). Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 78(13):1009-15.
  7. Rajabally YA, Uncini A. (2012). Outcome and its predictors in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 83(7):711-8.
  8. “Guillain-Barré Syndrome Fact Sheet.” National Institute of Neurological Disorders and Stroke, 16 Mar. 2020. Available at: www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-sheets/Guillain-Barr%C3%A9-Syndrome-Fact-Sheet.
  9. “Miller Fisher Syndrome Information Page: What research is being done?” National Institute of Neurological Disorders and Stroke, 27 Mar. 2019. Available at: www.ninds.nih.gov/Disorders/All-Disorders/Miller-Fisher-Syndrome-Information-Page.
  10. “Guillain-Barré Syndrome.” Centers for Disease Control and Prevention, 20 Dec. 2019. Available at: www.cdc.gov/campylobacter/guillain-barre.html.

Previous Chapter

Preventing Guillain-Barré syndrome (GBS)

Next Chapter

Symptoms of Guillain-Barre syndrome

Connect with Marler Clark

Office:

1012 First Avenue
Fifth Floor
Seattle, WA 98104

Hours:

M-F, 8:30 am - 5:00 pm, Pacific

Call toll free:

1 (800) 884-9840

If you have questions about foodborne illness, your rights or the legal process, we’d be happy to answer them for you.